LXRX icon

Lexicon Pharmaceuticals
LXRX

Overview Fund Activity

86 hedge funds and large institutions have $221M invested in Lexicon Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 17 closing their positions.

Holders
86
Holders Change
-15
Holders Change %
-14.85%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
30
Reduced
31
Closed
17
Calls
$475K
Puts
$129K
Net Calls
+$346K
Net Calls Change
+$242K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$1.06M
2
IHAM
2
Integral Health Asset Management
New York
$558K
3
PHP
3
Parkman Healthcare Partners
Connecticut
$465K
4
Fisher Asset Management
4
Fisher Asset Management
Washington
$1.13M
5
GCP
5
GSA Capital Partners
United Kingdom
$691K

Top Sellers

1
Nomura Holdings
1
Nomura Holdings
Japan
$410K
2
Citadel Advisors
2
Citadel Advisors
Florida
$308K
3
HF
3
HRT Financial
New York
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.3M
5
Walleye Capital
5
Walleye Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CSS
101
Cubist Systematic Strategies
Connecticut
– – -10,816 Closed
QT
102
Quantbot Technologies
New York
– – -3,625 Closed
PHK
103
Point72 Hong Kong
Hong Kong
– – -3,603 Closed
PVI
104
Pura Vida Investments
New York
– – – –
CFGS
105
Concourse Financial Group Securities
Alabama
– – – –
PA
106
Parallel Advisors
California
– – – –
HT
107
HAP Trading
New York
– – – –
1 2 3 4
5